Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.657, 2012-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QuantiFERON TB Gold: cost-effective screening for TB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. :
Access to resources
Recommend
Rivaroxaban cost effective in various settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 567, 2008-01 ,pp. :
Rivaroxaban cost effective in various settings
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :
Isoniazid programme to prevent TB cost effective in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Isoniazid programme to prevent TB cost effective in the US
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :